Veterinary GS-441524 Tablets 20mg 40mg 50mg 60mg Oral Formula for Feline Infectious Peritonitis Care

Product Introduction

GS-441524 tablets are formulated to provide an oral administration option for veterinary FIP management programs. As feline infectious peritonitis (FIP) treatment continues to evolve, oral tablets have become a preferred choice in many situations because they are easy to administer, transport, and store during long-term care.

To support different treatment requirements, this product is available in 20mg, 40mg, 50mg, and 60mg tablet strengths. Multiple dosage options make it easier to adjust treatment according to the cat's body weight and the veterinarian's recommendations, while also improving flexibility throughout different stages of care.

The tablets are manufactured under standardized production systems with quality inspections carried out throughout the manufacturing process, helping ensure batch consistency and dependable product quality.

Key Features

Available in Four Strengths

Providing several dosage strengths allows treatment plans to be tailored more accurately for individual cats.

Available options include:

• 20mg for kittens, lightweight cats, or gradual dose adjustment.
• 40mg for routine daily administration in many treatment programs.
• 50mg for reducing tablet quantity while maintaining dosing flexibility.
• 60mg for cats requiring higher daily antiviral support.

The variety of strengths allows veterinarians to combine tablets more efficiently according to changing treatment needs.

Easy Oral Administration

Oral tablets eliminate the need for daily injections in appropriate situations, making medication routines simpler for many caregivers and reducing handling stress for cats.

Consistent Manufacturing Standards

Every production batch follows controlled manufacturing procedures and quality verification to help maintain uniform tablet quality and stable product performance.

Designed for Reliable Storage

The formulation remains stable under recommended room-temperature storage conditions and is packaged to protect product quality during transportation.

Understanding FIP

Feline infectious peritonitis is a progressive disease that develops after feline coronavirus mutates inside the body. While coronavirus infection is common in cats, only a small percentage develop FIP.

Depending on the organs involved, FIP is generally classified into several clinical forms:

• Effusive (Wet) FIP, characterized by fluid accumulation in the abdomen or chest.
• Non-Effusive (Dry) FIP, involving inflammatory lesions affecting internal organs.
• Ocular FIP, which may cause inflammation inside the eyes.
• Neurological FIP, affecting the brain and nervous system.

Clinical signs vary considerably between patients, making individualized veterinary assessment an important part of treatment planning.

Suitable Applications

GS-441524 tablets are supplied for professional veterinary use in a variety of environments, including:

• Veterinary clinics and hospitals
• Animal health centers
• Cat rescue organizations
• Breeding facilities
• Veterinary distributors
• Home care supervised by veterinary professionals

The multiple tablet strengths provide flexibility for treatment plans throughout different stages of FIP management.

Storage Instructions

To maintain product stability:

• Store in a dry place at room temperature.
• Keep tablets sealed inside the original container.
• Avoid direct sunlight and excessive moisture.
• Do not expose the product to prolonged high temperatures.

Proper storage helps preserve tablet quality and stability until use.

Manufacturing Quality

The production process follows standardized quality management procedures from raw material selection through final packaging. Batch records and product identification systems support traceability and quality consistency for every shipment.

Designed for veterinary distribution, GS-441524 tablets combine convenient oral administration with multiple dosage options to meet a wide range of feline healthcare requirements.

Important Notice

This product is intended for veterinary use only.

Treatment decisions, dosage selection, and administration schedules should be determined by a licensed veterinarian according to the individual cat's diagnosis, body weight, and response to therapy.